Aussie rock singer and popular The Voice contestant Virginia Lillye fights stage three ovarian cancer
The Sydneysider , 54, is best known to many Aussies for being on season nine of The Voice in 2020 where she made it through to the top 20 showdown rounds as part of Boy George 's team. (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2023 Category: Consumer Health News Source Type: news

Scandal of the NHS 'never-events': Bungling hospital medics are wrongly removing ovaries and leaving drill bits INSIDE patients once a day, shocking audit reveals... so is YOUR trust one of the worst offenders?
EXCL: A MailOnline audit of a decade's worth of NHS data found a colossal 4,300 never-events have occurred in England since 2013.This equates to roughly eight a week. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2023 Category: Consumer Health News Source Type: news

Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer
(MedPage Today) -- SEOUL, South Korea -- Treatment with the bispecific antibody ubamatamab alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo) appeared to be safe and demonstrated activity in patients with recurrent ovarian cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 10, 2023 Category: Hematology Source Type: news

Key Updates in Ovarian Cancer From ESMO 2023 Key Updates in Ovarian Cancer From ESMO 2023
Highlights in ovarian cancer from ESMO 2023 include results on first-line use of a PARP inhibitor and on the addition of immunotherapy to platinum-based chemotherapy, and PARP inhibition after relapse.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news

Osmolality Analysis in Bioprocessing: From Theory to Practice, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insights into the role of monitoring osmolality in bioprocessing research. Attendees will learn about using osmolality analysis in Chinese hamster ovary (CHO) cell health studies. The featured speakers will discuss current uses and future potential for... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 6, 2023 Category: Pharmaceuticals Source Type: news

Compugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity in Patients Typically Not Responding to Immunotherapy
COM701 + nivolumab + BMS-986207 (anti-TIGIT) resulted in clinically meaningful durable partial responses> 16 months in platinum resistant ovarian cancer patients COM701 dual and triple combinations mediated clinical benefit in platinum resistant ovarian cancer patients, independent of... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 6, 2023 Category: Pharmaceuticals Tags: TRI TDS Source Type: news

RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer
(MedPage Today) -- SEOUL, South Korea -- The combination of avutometinib and defactinib achieved "exceptionally" high response rates in heavily pretreated patients with recurrent low-grade serous ovarian cancer (LGSOC), according to the ENGOT... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 6, 2023 Category: Hematology Source Type: news

Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters, prompts life-changing decisions
(Sisters left to right: Chris Swatfager, Cindy Larson, Carrie Patnode and Amy Scheid. Photo is courtesy of Chris Swatfager.) Sisters often share certain genetic traits, such as hair color and facial features. But for three sisters from Minnesota, they discovered a much deeper connection — a shared genetic mutation known to dramatically increase their risk for breast and ovarian cancer. Their BRCA1 variants came to light through a Mayo Clinic Center for Individualized Medicine DNA sequencing study. The… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 4, 2023 Category: Databases & Libraries Source Type: news

Four women have groundbreaking two-in-one surgery to reduce their risk of ovarian cancer while undergoing a C-section
Claire Rodrigues Lee (pictured), 45, was one of the four women, who were treated at UCLH, were all carriers of the BRCA1 or BRCA2 gene alterations which put them at higher risk of the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2023 Category: Consumer Health News Source Type: news

Pioneering operation combines cancer surgery and Caesarean
Four women have had a landmark two-in-one operation to reduce the inherited risk of ovarian cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 2, 2023 Category: Consumer Health News Source Type: news

Celiac Disease and Higher Risk of Women's Health Disorders Celiac Disease and Higher Risk of Women's Health Disorders
Women with celiac disease face a much higher risk of other health complications, including ovarian failure, endometriosis, and pregnancy loss, a large new study suggests.WebMD Health News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 2, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Johnson & Johnson Considers 3rd Bankruptcy for Talc Litigation
Johnson & Johnson may be filing for bankruptcy for a third time in an attempt to address its talc liabilities, this time under a different corporate structure. The pharmaceutical giant has twice failed at “Texas Two-Step” filings to resolve mass tort litigation against it. Roughly 51,000 lawsuits filed against Johnson & Johnson claim the company’s talc-based products caused them to develop cancer. Johnson & Johnson’s two Chapter 11 bankruptcy filings through its subsidiary, LTL Management, were both denied by a New Jersey judge who found LTL did not qualify for bankruptcy protection becau...
Source: Asbestos and Mesothelioma News - November 2, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Legal Source Type: news

Celiac Disease and Higher Risk of Women ’s Health Disorders
Women with celiac disease had significantly higher rates of polycystic ovary syndrome, irregular menstruation, and infertility, compared to women without the condition, a study says. (Source: WebMD Health)
Source: WebMD Health - November 1, 2023 Category: Consumer Health News Source Type: news

MRI superior in characterizing high-risk adnexal lesions
MRI has advantages over transvaginal ultrasound (TVUS) when characterizing adnexal lesions based on the Ovarian-Adnexal Imaging-Reporting-Data System (O-RADS), according to findings published October 27 in the European Journal of Radiology. A team led by Isabelle Thomassin-Naggara, MD, PhD, from the Assistance Publique–Hôpitaux de Paris in France, found that MRI is on par with TVUS when it comes to sensitivity, but it has higher specificity. “MRI should be the recommended second-line technique when a mass is discovered during TVUS and is rated O-RADS 4 and 5 over than TVUS by an ultrasound specialist,” the Thomas...
Source: AuntMinnie.com Headlines - October 30, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: MRI Ultrasound Womens Imaging Source Type: news

Tennis Star Pete Sampras Reveals Wife and Actress Bridgette Wilson-Sampras Has Ovarian Cancer
Former tennis star Pete Sampras revealed his wife, actress Bridgette Wilson-Sampras, has ovarian cancer. In a statement posted on the ATP Tour’s official social media account, Sampras shared a lengthy statement explaining that though he is typically a quiet and private person, he wanted to share…#petesampras #atp #tour #wilsonsampras #christian #billymadison #veronicavaughan #adamsandlersbilly #bell #santabarbara (Source: Reuters: Health)
Source: Reuters: Health - October 29, 2023 Category: Consumer Health News Source Type: news